Skip to main content

Advertisement

Log in

Vascular neurobehcet disease:correlation with current disease activity forum and systemic vascular involvement

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Behcet’s syndrome (BS) is a chronic relapsing vascular inflammatory disease of unknown etiology with high morbidity and mortality. This research aims to study the clinical patterns of CNS disease in a group of patients with BS as well as the frequency and type of the associated radiographic findings suggestive of structural cerebral vascular disease. The findings were studied in relation to disease activity and features of systemic vascular involvement. Forty patients fulfilling the diagnostic criteria of the International Study Group for Behcet’s Disease, mean age of 33.56 ± 9.7 years, were enrolled. Patients were subjected to magnetic resonance imaging with conjugate survey of cerebral blood vessels’ flow pattern abnormalities by transcranial Doppler study. Thirty healthy controls were included. Behcet’s Disease Current Activity Form Score was used. Neuro-Behcet’s syndrome (NBS) was diagnosed in 37.5% with headache being the most common (86.6% of cases), pyramidal affection (signs of upper motor neuron lesions/hemiplegia) was reported in 33.3%, attacks of disturbed conscious level in 26.6%, and cranial nerve affection in 6.5%. Of the patients, 66.6% with clinical features of NBS had statistically significant radiographic evidences of cerebrovascular disease (p = 0.01). Patients with NBS had significantly higher disease activity index score (r = 0.69, p = 0.0001). Radiographic findings and flow abnormalities were significantly less in patients on immune suppressants and antiplatelet drugs (p = 0.003, 0.04). BS patients with clinical neurologic disease were found to have radiographic findings suggestive of cerebral vascular disease with high disease activity index score. Drugs like immunosuppressants and oral antiplatelets might retard cerebral vascular disease progression and flow abnormalities, respectively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Siva A, Saip S (2009) The spectrum of nervous system involvement in Behçet’s syndrome and its differential diagnosis. J Neurol 256(4):513–529

    Article  PubMed  Google Scholar 

  2. Akpolat T, Akkoyunlu M, Akpolat I, Dilek M, Odabas AR, Ozen S (2002) Renal Behçet’s disease: a cumulative analysis. Semin Arthritis Rheum 31(5):317–337

    Article  PubMed  Google Scholar 

  3. Jorizzo JL, Hudson RD, Schmalstieg FC, Daniels JC, Apisarnthanarax P, Henry JC, Gonzalez EB, Ichikawa Y, Cavallo T (1984) Behçet’s syndrome: immune regulation, circulating immune complexes, neutrophil migration, and colchicine therapy. J Am Acad Dermatol 10(2 Pt 1):205–214

    Article  PubMed  CAS  Google Scholar 

  4. Siva A, Fresko II (2000) Behçet’s disease. Curr Treat Options Neurol 2(5):435–448

    Article  PubMed  Google Scholar 

  5. Siva A (2001) Vasculitis of the nervous system. J Neurol 248(6):451–468, Review

    Article  PubMed  CAS  Google Scholar 

  6. Siva A, Altintas A, Saip S (2004) Behçet’s syndrome and the nervous system. Curr Opin Neurol 17(3):347–357

    Article  PubMed  Google Scholar 

  7. Tunc R, Saip S, Siva A, Yazici H (2004) Cerebral venous thrombosis is associated with major vessel disease in Behçet’s syndrome. Ann Rheum Dis 63(12):1693–1694

    Article  PubMed  CAS  Google Scholar 

  8. Saip S, Siva A, Altintas A, Kiyat A, Seyahi E, Hamuryudan V, Yazici H (2005) Headache in Behcet’s syndrome. Headache 45(7):911–919

    Article  PubMed  Google Scholar 

  9. Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, Houman MH, Kötter I, Olivieri I, Salvarani C, Sfikakis PP, Siva A, Stanford MR, Stübiger N, Yurdakul S, Yazici H (2009) Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease. Ann Rheum Dis 68(10):1528–1534

    Article  PubMed  CAS  Google Scholar 

  10. Wang LY, Zhao DB, Gu J, Dai SM (2010) Clinical characteristics of Behçet’s disease in China. Rheumatol Int 30(9):1191–1196

    Article  PubMed  CAS  Google Scholar 

  11. Siva A, Yazıcı H (2004) Behcet’s disease. In: Levine S, Doruk E (eds) Handbook of systemic autoimmune diseases, neurology volume—the neurologic ınvolvement in systemic autoimmune disorders. Elsevier Science, New York

    Google Scholar 

  12. Lawton G, Bhakta BB, Chamberlain MA, Tennant A (2004) The Behçet’s Disease Activity Index. Rheumatology 43:73–78

    Article  PubMed  CAS  Google Scholar 

  13. International Study Group for Behcet’s disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335:1078–1080

    Google Scholar 

  14. Serdaroflu P, Yazici H, Ozdemir C, Yurdakul S, Bahar S, Aktin E (1989) Neurologic involvement in Behçet’s syndrome. A prospective study. Arch Neurol 46(3):265–269

    Article  Google Scholar 

  15. Farah S, Al-Shubaili A, Montaser A (1998) Behçet’s syndrome: a report of 41 patients with emphasis on neurological manifestations. J Neurol Neurosurg Psychiatry 64:382–384

    Article  PubMed  CAS  Google Scholar 

  16. Akman-Demir G, Serdaroglu P, Tasçi B, the Neuro-Behçet Study Group (1999) Clinical patterns of neurological involvement in Behçet’s disease: evaluation of 200 patients. Brain 122:2171–2182

    Article  PubMed  Google Scholar 

  17. Kidd D, Steuer A, Denman AM, Rudge P (1999) Neurological complications of Behçet’s syndrome. Brain 122:2183–2194

    Article  PubMed  Google Scholar 

  18. Siva A, Kantarci OH, Saip S, Altintas A, Hamuryudan V, Islak C, Kocer N, Yazici H (2001) Behçet’s disease: diagnostic and prognostic aspects of neurological involvement. J Neurol 248:95–103

    Article  PubMed  CAS  Google Scholar 

  19. Nadeau SE (2002) Neurologic manifestations of connective tissue disease. Neurol Clin 20:151–178

    Article  PubMed  Google Scholar 

  20. Ashjazadeh N, Borhani Haghighi A, Samangooie S, Moosavi H (2003) Neuro-Behçet’s disease: a masquerader of multiple sclerosis. A prospective study of neurologic manifestations of Behçet’s disease in 96 Iranian patients. Exp Mol Pathol 74:17–22

    Article  PubMed  CAS  Google Scholar 

  21. Al-Araji A, Sharquie K, Al-Rawi Z (2003) Prevalence and patterns of neurological involvement in Behçet’s disease: a prospective study from Iraq. J Neurol Neurosurg Psychiatry 74:608–613

    Article  PubMed  CAS  Google Scholar 

  22. Barros R, Santos E, Moreira B et al (2007) Clinical characterization and pattern of neurological involvement of Behçet’s disease in fifteen Portuguese patients. Clin Exp Rheumatol 24(suppl 42):S31

    Google Scholar 

  23. Byung-Sik C, Hyun-Sook K, Su-Jin O, Hyeok-Jae K, Chong-Hyun Y, So-Lyung J, Do-June M, Wan-Uk K (2007) Comparison of the clinical manifestations, brain MRI and prognosis between neuroBehçet’s disease and neuropsychiatric lupus. Korean J Intern Med 22(2):77–86

    Article  Google Scholar 

  24. Yazici H, Fresko I, Yurdakul S (2007) Behçet’s syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 3:148–155

    Article  PubMed  Google Scholar 

  25. Inaba G (1986) Clinical features of neuro-Behçet syndrome. In: Lehner T, Barnes CG (eds) Recent advances in Behçet’s disease. International Congress and Symposium Series Number 103. Royal Society of Medicine Services, London, pp 235–246

    Google Scholar 

  26. Siva A, Necdet V, Yurdakul S, Yardim M, Denktaş F, Yazici H (1991) Neuro-radiologic findings in neuro-Behçet syndrome. In: O’DuffyI D, Kokmen E (eds) Behçet’s disease: basic and clinical aspects. Dekker, New York, pp 323–329

    Google Scholar 

  27. Kocer N, Islak C, Siva A, Saip S, Akman C, Kantarci O, Hamuryudan V (1999) CNS involvement in neuro-Behçet’s syndrome: an MR study. AJNR Am J Neuroradiol 20:1015–1024

    PubMed  CAS  Google Scholar 

  28. Turker H, Terzi M, Bayrak O, Cengiz N, Onar M, Us O (2008) Visual evoked potentials in diff erential diagnosis of multiple sclerosis and neurobehçet’s disease. Tohoku J Exp Med 216:109–116

    Article  PubMed  Google Scholar 

  29. Mnif N, Bourkhis S, Salem A, Mehiri S, Ben Amara F, Rajhi H, Hamza R (2010) Neurobehcet disease 34 patients study. Department of Diagnostic Radiology Charles Nicolle Hospital, Tunisia, Online article. http://peicr.sfrnet.org/Data/ModuleConsultationPoster/PDF/2008/e74ecada-5060-4047-87b8-e375da05e148.pdf

Download references

Disclosures

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Reem H. A. Mohammed.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mohammed, R.H.A., Nasef, A., Kewan, H.H. et al. Vascular neurobehcet disease:correlation with current disease activity forum and systemic vascular involvement. Clin Rheumatol 31, 1033–1040 (2012). https://doi.org/10.1007/s10067-012-1953-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-012-1953-0

Keywords

Navigation